Related Experiment Videos
Bacterial efflux pump inhibition
1John D Dingell Veteran's Affairs Medical Center, Detroit, Ml 148201, USA. gkaatz@juno.com
Current Opinion in Investigational Drugs (London, England : 2000)
|March 9, 2005
Summary
Inhibiting bacterial multidrug efflux pumps can restore antimicrobial drug effectiveness and potentially lower the cost of developing new antibiotics. This strategy combats antimicrobial resistance by overcoming drug extrusion mechanisms.
Area of Science:
- Microbiology
- Molecular Biology
- Pharmacology
Background:
- Drug efflux is a key mechanism of antimicrobial resistance in bacteria.
- Multidrug efflux pumps, a class of membrane proteins, extrude diverse antimicrobial agents.
- These pumps contribute to intrinsic, acquired, and mutational resistance.
Purpose of the Study:
- To highlight the clinical relevance of drug efflux mechanisms in bacterial resistance.
- To emphasize the potential of inhibiting multidrug efflux pumps to combat antimicrobial resistance.
- To explore the economic benefits of developing efflux pump inhibitors.
Main Methods:
- Review of in vitro and in vivo investigations on efflux pump inhibitors.
- Analysis of the impact of efflux pump inhibition on antimicrobial activity.
- Examination of the role of protein superfamilies in drug transport.
Main Results:
- Inhibition of efflux pumps can decrease bacterial resistance to antibiotics.
- Combining efflux pump inhibitors with existing drugs can restore their clinical efficacy.
- Broad-spectrum efflux pump inhibitors may reduce the need for novel antimicrobial drug discovery.
Conclusions:
- Targeting bacterial multidrug efflux pumps is a promising strategy against antimicrobial resistance.
- Efflux pump inhibitors can re-sensitize bacteria to previously ineffective antimicrobial agents.
- Development of broad-spectrum efflux pump inhibitors could significantly impact antibiotic development costs and strategies.